CLINICAL_TRIALS ClinicalTrials.gov record update

US Early Access Program for the Treatment of Patients With C3 Glomerulopathy or Primary Immune-Complex Membranoproliferative Glomerulonephritis With Pegcetacoplan

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04729062
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:29:00.208967+00:00
Published At: 2025-11-06T00:00:00+00:00
Record Updated At: 2025-11-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["C3G", "IC-MPGN", "C3 Glomerulopathy", "C3 Glomerulonephritis", "Complement 3 Glomerulopathy", "Complement 3 Glomerulopathy (C3G)", "Complement 3 Glomerulonephritis", "Dense Deposit Disease", "DDD", "Membranoproliferative Glomerulonephritis", "Membranoproliferative Glomerulonephritis (MPGN)", "Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-11-06"
protocolSection.identificationModule.nctId: "NCT04729062"
protocolSection.identificationModule.officialTitle: "US Early Access Program for the Treatment of Patients With C3 Glomerulopathy or Primary Immune-Complex Membranoproliferative Glomerulonephritis With Pegcetacoplan"
protocolSection.statusModule.overallStatus: "APPROVED_FOR_MARKETING"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.